Thus, cysteine residues susceptible to oxidative modifications are critical for exacerbation of APAP-mediated hepatotoxicity in human, suggesting that TRP channels such as TRPC1 and TRPV1 susceptible to this type of modification are potential targets for the treatment of APAP-induced liver toxicity. The gene discussed is TRPV1; the disease is toxicity.